Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05520528 · ClinicalTrials.gov registry record · NA

Impact of Group Participation on Adults With Aphasia

A NA study of Stroke and Rehabilitation, sponsored by University of Arkansas.

Active
Registry status
NA
Development phase
40
Enrollment target
1
Study location

NCT05520528: Active NA study of Stroke and Rehabilitation, sponsored by University of Arkansas.

NCT05520528 is a NA study of Stroke and Rehabilitation that is active but no longer recruiting, run by University of Arkansas. The registered enrollment target is 40 participants, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05520528, a NA study of Stroke and Rehabilitation, is active but no longer recruiting, sponsored by University of Arkansas.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

The purpose of the study is to examine the impact of group participation on adults with aphasia. Participants will complete a standard pre-and post-assessment of language abilities (speech, comprehension, reading, and/or writing). Then participants will attend 90-minute weekly reading group sessions during an academic semester.

Primary Outcome

To determine if group participation improves intervention-specific language skills in reading comprehension by comparing baseline score to 1-week post-intervention score

Interventions

  • BEHAVIORAL Language intervention with group sessions and independent tasks with emphasis on improving reading and writing skills among persons with aphasia

Study Locations (1)

Arkansas

  • UAM CHP Speech-Language and Hearing Clinic - Little Rock

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2022-09-06
Est. Completion 2026-12-15
Phase NA
University of Arkansas

318 total trials

What the registry record for NCT05520528 still lists

NCT05520528 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower).

The record links to 4 conditions, with Stroke appearing as the primary indexed condition, and to 1 intervention - of which Language intervention with group sessions and independent tasks with emphasis on improving reading and writing skills among persons with aphasia is the first listed.

NCT05520528 reports a single indexed study location in Arkansas.

Frequently Asked Questions

What is clinical trial NCT05520528 about?

NCT05520528 is a clinical study titled "Impact of Group Participation on Adults With Aphasia". The purpose of the study is to examine the impact of group participation on adults with aphasia. Participants will complete a standard pre-and post-assessment of language abilities (speech, comprehension, reading, and/or writing). Then participants will attend 90-minute weekly reading group sessions...

What is the current status of trial NCT05520528?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2022-09-06. Estimated completion is 2026-12-15.

What conditions does trial NCT05520528 study?

This clinical trial studies the following conditions: Stroke, Rehabilitation, Aphasia, Acquired, Language Disorder, Acquired.

What interventions are being tested in trial NCT05520528?

The interventions under investigation include: Language intervention with group sessions and independent tasks with emphasis on improving reading and writing skills among persons with aphasia (BEHAVIORAL).

Who is sponsoring clinical trial NCT05520528?

This trial is sponsored by University of Arkansas, which has 318 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05520528 being conducted?

This trial has 1 study location across Arkansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Stroke

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05520528's enrollment target sits among peer trials

40 262nd of 454 higher than 181 of 454 other Stroke trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Stroke trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01306019 · 40 participants · Phase 1

    Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)

  • NCT01608152 · 40 participants

    Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors

  • NCT01668082 · 40 participants · NA

    An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection

  • NCT02015013 · 40 participants · Phase 2

    Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05520528, the US trial registry maintained by the National Library of Medicine. NCT05520528 (small enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.